Search

Subscribe for email alerts

To receive MDxHealth email alerts, please fill in your contact information, select the items you would like to receive, and click the submit button.

Send me company info alerts for the following lists

Subscribe Unsubscribe

Shareholder Information

Key Shareholder Information

Corporate Presentation

An overview of the most recent information about MDxHealth can be found in the company’s periodic corporate presentation slides. The latest MDxHealth Corporate Presentation can be downloaded here.

Corporate Governance Charter

MDxHealth attaches great value to corporate governance practices.
On September 7, 2011, our board of directors approved the current version of MDxHealth’s Corporate Governance Charter. The Charter has been drafted in accordance with the principles and the provisions of the Belgian Corporate Governance Code 2009 issued on March 12, 2009 by the Corporate Governance Committee.

The full text of MDxHealth’s Corporate Governance Charter can be downloaded here.

Dealing Code

As a listed company, MDxHealth must comply with rules governing insider trading. The company's dealing code can be found here.

Articles of Association

The Articles of Association are periodically updated. The latest version (October 14, 2013) can be found here:

English version

Version Française

Share capital history

The history of the share capital issuance since the inception of the company can be found here:

History of share capital since incorporation

Transparency Declarations of the largest shareholders

Shareholders holding more than 3% of the company’s outstanding shares have provided the company with the notifications of their shareholding. The most recent notifications are here:

Summary of transparency declarations received as per July 9, 2013

History of transparency declarations received as per July 9, 2013

Each natural or legal person acquiring or transferring MDxHealth’s shares is required to notify MDxHealth and the Financial Services and Markets Authority (FSMA) each time their shareholding crosses a threshold of three percent (3%) of the total number of outstanding shares (the denominator). Such notification is also required each time, as a result of an acquisition or transfer a threshold of five percent (5%) and a multiple of five percent (5%) is crossed. Complete information regarding this requirement is found in Article 14 of MDxHealth’s articles of association.

The transparency notifications should be reported within 5 business days of crossing the threshold by following the procedures outlined on the FSMA website found here.

A copy of the transparency notification should also be emailed and faxed to the company, to the attention of: Francis Ota, EVP of Finance, at This e-mail address is being protected from spambots. You need JavaScript enabled to view it and fax +32 4 364 20 71.

Total statutory capital EUR 27,321,762.02
Total number of voting rights (one voting right per share) in MDxHealth SA (denominator) 34,251,303
Potential future voting rights attached to shares to be issued upon exercise of the 1,003,163 warrants currently outstanding from the 1,327,163 warrants currently existing (at June 24, 2013) 1,132,315

Annual and Extraordinary Shareholders' Meetings

The annual general shareholders’ meeting is held at the registered office or at the place determined in the notice convening the shareholders’ meeting. The meeting is held every year on the last Friday of May at 10 a.m. The notice and agenda, as well as a model of power of attorney are made available here at least 30 calendar days prior to the annual shareholders' meeting.

Next Shareholder's Meeting Material

Recent Shareholder's Meetings

June 27th, 2013, extraordinary general shareholder meeting minutes (with correction) - Français

June 27th, 2013, extraordinary general shareholder meeting minutes (with error) - Français

May 31st, 2013 : annual general shareholders' meeting minutes - Français

May 31, 2013, extraordinary general shareholder meeting non proceedings minutes - Français

May 25, 2012, board report for extraordinary general shareholders' meeting - English

May 25, 2012, board report for extraordinary general shareholders' meeting - Français

May 25, 2012, annual general shareholders' meeting minutes - Français

May 25, 2012, extraordinary general shareholder meeting non-proceedings minutes - Français

June 21, 2011, extraordinary general shareholder meeting minutes - Français

May 27, 2011, annual general shareholders' meeting minutes - Français

February 18, 2011, extraordinary general shareholder meeting minutes

February 18, 2011 board report for extraordinary general shareholders' meeting - Français

February 18, 2011 board report for Extraordinary General Shareholders' meeting - English

May 28, 2010, annual general shareholder meeting minutes - Français

April 6, 2010, extraordinary general shareholders meeting - English

April 6, 2010, extraordinary general shareholders meeting

May 29, 2009, annual general shareholder meeting minutes

May 30, 2008, extraordinary general shareholder meeting minutes

May 30, 2008, annual general shareholder meeting minutes

Analyst Coverage

Bank Analyst
Kempen & Co Mark Pospisilik
Petercam Roderick Verhelst

Please note that any opinions, estimates or forecasts made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of MDxHealth or its management. Requests for copies of analyst reports should be directed at the respective analyst and institution.

Paying Agent

The financial service for the shares of the company is provided in Belgium by ING. Shareholders should inform themselves about the costs that other financial intermediaries may charge in connection with paying agency services.

Special Reports of the Board and Auditor (in French language only)

Rapport du commissaire, articles 596 et 598, 24 juin 2013

Rapport du conseil d’administration, 24 juin 2013

Rapport du conseil d’administration, article 604, 30 avril 2013

Rapport du commissaire, articles 596 et 598, 28 juin 2012

Rapport du conseil d'administration, articles 603 juncto 596 et 598, 28 juin 2012

Rapport du conseil d'administration, articles 583/596/598, 18 avril 2012

Rapport du commissaire, articles 596/598, 19 avril 2012

Rapport du conseil d'administration, articles 583/596/598, 27 mai 2011

Rapport du commissaire, article 596, 27 mai 2011

Rapport du commissaire, article 596, 4 avril 2011

Rapport du conseil d'administration, article 603 juncto l'article 596, 4 avril 2011

Rapport du commissaire, Art. 582/596/598, 10 mai 2010

Rapport du conseil d’administration, articles 582/583/596/598, 21 juin 2010

Rapport du conseil d'administration, article 633, 10 mars 2010

Rapport du commissaire, article 596, 27 janvier 2009

Rapport du conseil d'administration, articles 583/596, 27 janvier 2009

Rapport du commissaire, article 596, 15 décembre 2008

Rapport du conseil d'administration, articles 603/596/589, 15 décembre 2008

Rapport du conseil d'administration, articles 583/596/589, 30 mai 2008

Rapport du commissaire, article 596, 26 mai 2008

Rapport du conseil d'administration, articles 604, 27 mars 2008

Rapport du conseil d'administration, articles 603/596, 15 octobre 2007

Rapport du commissaire, article 596, 15 octobre 2007

Rapport du conseil d'administration, articles 583/596/598, 25 mai 2007

Rapport du commissaire, articles 596/598, 21 mai 2007

Rapport du conseil d'administration, articles 583/596, 18 avril 2007

Rapport du commissaire, article 596, 16 avril 2007

Rapport du conseil d'administration, articles 583/596, 8 november 2006

Rapport du commissaire, article 596, 31 octobre 2006

View reports

Listing prospectus - April 2013

View reports

Listing prospectus - July 2012

View reports

Listing prospectus - April 2011

View reports